CAT vs GSK · P/E 48, rev $37.96B vs P/E 13, $103.31B cap
Caterpillar Inc (CAT) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE. It is led by Jim Umpleby.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported CAT revenue for 2026-06-30 was $37.96B. Net income was $6.14B. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
GSK does not have a complete income-statement cache yet.
CAT currently screens at market cap $440.29B and trailing P/E 47.7. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the CAT and GSK stock pages for the full models.
Not investment advice.